Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Operating Expenses | 1,590 | 1,560 | 3,771 | 2,881 | 3,065 |
| Operating Income | -1,590 | -1,560 | -3,771 | -2,881 | -3,065 |
| Other Income | 34 | 65 | 85 | 110 | 69 |
| Pre-tax Income | -1,556 | -1,495 | -3,686 | -2,771 | -2,996 |
| Income Tax | N/A | 14 | 102 | 26 | 36 |
| Net Income Continuous | -1,556 | -1,509 | -3,788 | -2,797 | -3,032 |
| Net Income | $-1,556 | $-1,509 | $-3,788 | $-2,797 | $-3,032 |
| EPS Basic Total Ops | -0.07 | -0.07 | -0.19 | -0.14 | -0.15 |
| EPS Basic Continuous Ops | -0.07 | -0.07 | -0.19 | -0.14 | -0.15 |
| EPS Diluted Total Ops | -0.07 | -0.07 | -0.19 | -0.14 | -0.15 |
| EPS Diluted Continuous Ops | -0.07 | -0.07 | -0.19 | -0.14 | -0.15 |
| EBITDA(a) | $-1,416 | $-1,093 | $-3,507 | $-2,590 | $-2,834 |